Andree Blaukat
Merck (Germany)(DE)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Cancer Research and Treatments, Liver physiology and pathology, Neuroendocrine Tumor Research Advances, DNA Repair Mechanisms
Most-Cited Works
- → PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect(2003)791 cited
- → Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins(2000)208 cited
- → Adaptor Proteins Grb2 and Crk Couple Pyk2 with Activation of Specific Mitogen-activated Protein Kinase Cascades(1999)207 cited
- → Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models(2020)160 cited
- → Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization(2008)154 cited
- Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.(2003)
- → A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease(2015)143 cited
- → EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors(2013)143 cited
- → Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts(1996)128 cited
- → Angiotensin-Converting Enzyme Inhibitor Ramiprilat Interferes With the Sequestration of the B 2 Kinin Receptor Within the Plasma Membrane of Native Endothelial Cells(1999)114 cited